Cargando…
Dosimetric Modeling of Lymphopenia in Patients With Metastatic Cancer Receiving Palliative Radiation and PD-1 Immune Checkpoint Inhibitors
PURPOSE: Radiation therapy (RT)–associated lymphopenia may adversely affect treatment outcomes, particularly in the era of immunotherapy. We sought to determine dosimetric factors correlated with lymphopenia after palliative RT in a cohort of patients with advanced cancer treated with anti-PD-1 immu...
Autores principales: | Qian, Jack M., Akama-Garren, Elliot, Shin, Jungwook, Gunasti, Lauren, Bang, Andrew, Pike, Luke R.G., Grassberger, Clemens, Schoenfeld, Jonathan D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783121/ https://www.ncbi.nlm.nih.gov/pubmed/35097241 http://dx.doi.org/10.1016/j.adro.2021.100880 |
Ejemplares similares
-
Dosimetric analysis of lymphopenia during chemoradiotherapy for esophageal cancer
por: Newman, Neil B., et al.
Publicado: (2020) -
Dosimetric Predictors of Treatment-related Lymphopenia induced by Palliative Radiotherapy: Predictive Ability of Dose-volume Parameters based on Body Surface Contour
por: Saito, Tetsuo, et al.
Publicado: (2016) -
Radiation-Induced Lymphopenia Risks of Photon Versus Proton Therapy for Esophageal Cancer Patients
por: Ebrahimi, Saba, et al.
Publicado: (2021) -
Dosimetric Effect of Thymus and Thoracic Duct on Radiation-Induced Lymphopenia in Patients With Primary Lung Cancer Who Received Thoracic Radiation
por: Zhang, Jinliang, et al.
Publicado: (2023) -
Radiotherapy-related lymphopenia in patients with advanced non-small cell lung cancer receiving palliative radiotherapy
por: Abravan, Azadeh, et al.
Publicado: (2020)